Morgan Stanley Finance LLC has taken a significant step in the financial services sector by filing a free writing prospectus for a new investment product. This filing, dated November 2, 2026, outlines a dual directional trigger investment linked to the Russell 2000 and S&P 500 indices. This strategic move is expected to bolster the company's offerings and attract a diverse range of investors seeking innovative financial solutions.

The filing indicates that the product, termed the "Worst-of RTY and SPX Dual Directional Trigger PLUS," is designed to provide investors with potential returns based on the performance of the worst-performing underlying index. The maturity date for this product is set for December 5, 2030, with a pricing date of November 30, 2026. The estimated value per security is projected at $955.80, with a margin of error of $45.00.

Background

Morgan Stanley Finance LLC is a subsidiary of Morgan Stanley, a leading global financial services firm. The company operates under the Standard Industrial Classification (SIC) code 6211, which encompasses security brokers, dealers, and flotation companies. As a significant player in the financial services industry, Morgan Stanley Finance LLC aims to provide a range of investment products and services to meet the needs of its clients.

Recent filings from the company on November 2, 2026, also include multiple free writing prospectuses and preliminary pricing supplements, indicating a robust strategy to engage investors with various offerings. The company's business address is located at 1585 Broadway, New York, NY, and it can be reached at (212) 761-4000.

What the Filing Says

The free writing prospectus outlines key terms of the new investment product, including:

  • Issuer: Morgan Stanley Finance LLC
  • Guarantor: Morgan Stanley
  • Underliers: Russell 2000 Index (RTY) and S&P 500 Index (SPX)
  • Leverage Factor: 130.50% to 145.50%
  • Absolute Return Participation Rate: 50%
  • Downside Threshold Level: 70% of the initial level for each underlier
  • Maturity Date: December 5, 2030

These details highlight the product's structure and potential benefits, making it an attractive option for investors looking for exposure to major market indices.

Impact

This new product may affect a wide range of stakeholders, including individual investors, institutional clients, and competitors within the security brokers and dealers sector. The innovative structure of the investment product could attract new clients seeking unique investment opportunities, while also prompting competitors to enhance their offerings to maintain market share.

What's Next

The filing does not specify what happens next, but the upcoming pricing date on November 30, 2026, will likely be a critical moment for the product's launch and investor engagement.

For more details, refer to the filing with accession number 0001839882-26-054285.